Andere talen PURE Bioscience, Inc.

Aandelen

PURE

US74621T2096

Vertraagde tijd OTC Markets Andere beurzen 15:32:03 09-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,074 ^USD	-12,84%		+5,71%	-42,95%

06/05	PURE Bioscience benoemt Darin Zehr tot lid van de Raad van Bestuur	CI
18/03	PURE Bioscience, Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 januari 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PURE Bioscience Appoints Darin Zehr to Board of Directors	06/05
PURE Bioscience Appoints Darin Zehr to Board of Directors	06/05
PURE Bioscience, Inc. announced that it has received $3 million in funding	22/03
PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	18/03
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results	18/03
PURE Bioscience, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	14/12
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results	14/12
PURE Bioscience, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	30-10-23
PURE Bioscience Reports Fiscal 2023 Financial Results	30-10-23
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting	05-07-23
PURE Bioscience, Inc. announced that it has received $1.8 million in funding	03-07-23
PURE Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	14-06-23
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results	14-06-23
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)	21-03-23
Pure Bioscience, Inc. Announces CEO Changes	21-03-23
Pure Bioscience, Inc. Announces Management Changes	21-03-23
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results	20-03-23
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	17-03-23
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results	17-03-23
PURE BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	10-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PURE Bioscience, Inc.

Aandelen

PURE

US74621T2096

Andere talen

Filters